Clinical Trials by Cancer Type
Learn More About This Topic: Chat with Us | Email Us
A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer
A Phase I/II Study of the Safety and Biological Activity of Intraperitoneal EGEN-001 (IL-12 plasmid formulated with PEG-PEI- Cholesterol lipopolymer) Administered alone and in Combination with Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients who had Previously Received Cytoreductive Surgery plus HIPEC Therapy.
Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC)
Protocol ET743-SAR-3002 Phase 3b: A Multicenter, Open-Label Single Arm Study of Yondelis(R)(Trabectedin)for Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapse or Are Refractory to Standard of Care